Neurospheres Modified To Produce Glial Cell Line-Derived Neurotrophic Factor Increase the Survival of Transplanted Dopamine Neurons (original) (raw)
Dopaminergic differentiation of grafted GFP transgenic neuroepithelial stem cells in the brain of a rat model of Parkinson's disease
Katherine Miller
Neuroscience Letters, 2007
View PDFchevron_right
Akerud, P., Canals, J.M., Snyder, E.Y. & Arenas, E. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J. Neurosci. 21, 8108-8118
Ernest Arenas
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience
View PDFchevron_right
Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease
Evan Snyder
The Journal of …, 2001
View PDFchevron_right
Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates
Bernard Schneider
Gene Therapy, 2005
View PDFchevron_right
Mouse Embryonic Stem Cells Expressing GDNF Show Enhanced Dopaminergic Differentiation and Promote Behavioral Recovery After Grafting in Parkinsonian Rats
Karla Soriano
2021
View PDFchevron_right
Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft’s ability to improve spontaneous motor behavior in parkinsonian rats
Bisera Georgievska
Neuroscience, 2006
View PDFchevron_right
Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells
Sangmi Chung
Parkinsonism & Related Disorders, 2001
View PDFchevron_right
The Colayer Method as an Efficient Way to Genetically Modify Mesencephalic Progenitor Cells Transplanted Into 6-OHDA Rat Model of Parkinson's Disease
Olga Baron
Cell Transplantation, 2012
View PDFchevron_right
Simultaneous transplantation of fetal ventral mesencephalic tissue and encapsulated genetically modified cells releasing GDNF in a hemi-parkinsonian rat model of Parkinson's disease
Morten Meyer
Cell transplantation, 2017
View PDFchevron_right
Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson’s disease: neurobehavioral, neurochemical and immunohistochemical studies
SANJEEV SHUKLA
International Journal of Developmental Neuroscience, 2003
View PDFchevron_right
Advances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review
Hao Xu, Susanne Schmid
Gerontology, 2015
View PDFchevron_right
Comparison of Fetal Mesencephalic Grafts, AAV-delivered GDNF, and Both Combined in an MPTP-induced Nonhuman Primate Parkinson’s Model
John Elsworth
Molecular Therapy, 2013
View PDFchevron_right
Cell Transplantation and Gene Therapy in Parkinson's Disease
Hemraj Dodiya
Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011
View PDFchevron_right
Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors
Eduardo martinez torres
Brain Research Bulletin, 2005
View PDFchevron_right
Intranigral Transplantation of Epigenetically Induced BDNF-Secreting Human Mesenchymal Stem Cells: Implications for Cell-Based Therapies in Parkinson's Disease
Mauricio Baes, Carlos Juri
Biology of Blood and Marrow Transplantation, 2010
View PDFchevron_right
Neural transplantation for treatment of Parkinson's disease
Patrik Brundin
Drug Discovery Today, 2002
View PDFchevron_right
Neurotrophic factor in the treatment of Parkinson disease
Young-bo Kim
Neurosurgical FOCUS, 2003
View PDFchevron_right
Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease
Shaul Reuveny
Stem cells translational medicine, 2017
View PDFchevron_right
Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease
Zaal Kokaia
Trends in Pharmacological Sciences, 2009
View PDFchevron_right
Advances in stem-cell--generated transplantation therapy for Parkinson's disease
Maria Sundberg
View PDFchevron_right
Cell-Based Therapies for Parkinson’s Disease: Preclinical and Clinical Perspectives
Susanne Schmid
Challenges in Parkinson's Disease, 2016
View PDFchevron_right
Viral Delivery of GDNF Promotes Functional Integration of Human Stem Cell Grafts in Parkinson’s Disease
Vanessa Penna
View PDFchevron_right
Delayed transplantation of precursor cell‐derived astrocytes provides multiple benefits in a rat model of Parkinsons
Joshua Munger
EMBO Molecular Medicine, 2014
View PDFchevron_right
Emerging regenerative medicine and tissue engineering strategies for Parkinson’s disease
Justin Burrell
npj Parkinson's Disease, 2020
View PDFchevron_right
Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson?s disease
Jingzhong Zhang
Experimental Brain Research, 2005
View PDFchevron_right
Encapsulated cell biodelivery of GDNF: A novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease?
Olle Lindvall, Lars Wahlberg
Experimental Neurology, 2008
View PDFchevron_right
Potential Use of Embryonic Stem Cells for the Treatment of Mouse Parkinsonian Models: Improved Behavior by Transplantation of In Vitro Differentiated Dopaminergic Neurons from Embryonic Stem Cells
Masahide Yoshikawa
Stem Cells, 2003
View PDFchevron_right
Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease
Guido Nikkhah, Marco Timmer
2009
View PDFchevron_right
Cell transplantation in Parkinsonʼs disease: problems and perspectives
Géraldine Petit
Current Opinion in Neurology, 2010
View PDFchevron_right
Rewiring the brain with cell transplantation in Parkinson's disease
Afsaneh Gaillard
Trends in Neurosciences, 2011
View PDFchevron_right
Potential cellular and regenerative approaches for the treatment of Parkinson’s disease
Olivia Handley
Neuropsychiatric Disease and Treatment, 2008
View PDFchevron_right